A Neanderthal OAS1 isoform protects individuals of European ancestry against COVID-19 susceptibility and severity
- 25 February 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Medicine
- Vol. 27 (4), 659-667
- https://doi.org/10.1038/s41591-021-01281-1
Abstract
To identify circulating proteins influencing Coronavirus Disease 2019 (COVID-19) susceptibility and severity, we undertook a two-sample Mendelian randomization (MR) study, rapidly scanning hundreds of circulating proteins while reducing bias due to reverse causation and confounding. In up to 14,134 cases and 1.2 million controls, we found that an s.d. increase in OAS1 levels was associated with reduced COVID-19 death or ventilation (odds ratio (OR) = 0.54, P = 7 × 10−8), hospitalization (OR = 0.61, P = 8 × 10−8) and susceptibility (OR = 0.78, P = 8 × 10−6). Measuring OAS1 levels in 504 individuals, we found that higher plasma OAS1 levels in a non-infectious state were associated with reduced COVID-19 susceptibility and severity. Further analyses suggested that a Neanderthal isoform of OAS1 in individuals of European ancestry affords this protection. Thus, evidence from MR and a case–control study support a protective role for OAS1 in COVID-19 adverse outcomes. Available pharmacological agents that increase OAS1 levels could be prioritized for drug development.This publication has 60 references indexed in Scilit:
- Homologous 2′,5′-phosphodiesterases from disparate RNA viruses antagonize antiviral innate immunityProceedings of the National Academy of Sciences of the United States of America, 2013
- Neandertal Origin of Genetic Variation at the Cluster of OAS Immunity GenesMolecular Biology and Evolution, 2013
- A High-Coverage Genome Sequence from an Archaic Denisovan IndividualScience, 2012
- Antagonism of the Interferon-Induced OAS-RNase L Pathway by Murine Coronavirus ns2 Protein Is Required for Virus Replication and Liver PathologyCell Host & Microbe, 2012
- Pharmacologic Activation of the Innate Immune System to Prevent Respiratory Viral InfectionsAmerican Journal of Respiratory Cell and Molecular Biology, 2011
- Extracellular 2′-5′ Oligoadenylate Synthetase Stimulates RNase L-Independent Antiviral Activity: a Novel Mechanism of Virus-Induced Innate ImmunityJournal of Virology, 2010
- Genetic Variation in OAS1 Is a Risk Factor for Initial Infection with West Nile Virus in ManPLoS Pathogens, 2009
- The primary function of RNA binding by the influenza A virus NS1 protein in infected cells: Inhibiting the 2′-5′ oligo (A) synthetase/RNase L pathwayProceedings of the National Academy of Sciences of the United States of America, 2006
- Polymorphisms of interferon-inducible genes OAS-1 and MxA associated with SARS in the Vietnamese populationBiochemical and Biophysical Research Communications, 2005
- ‘Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease?*International Journal of Epidemiology, 2003